Diamicron (Gliclazide)

Role

Indications

Reactions

Secondary

Type 2 Diabetes Mellitus	29.9%
Ill-defined Disorder	11.6%
Hypertension	10.9%
Drug Use For Unknown Indication	9.5%
Diabetes Mellitus	6.8%
Agitation	5.4%
Congestive Cardiomyopathy	5.4%
Dyslipidaemia	4.1%
Diabetes Insipidus	2.0%
Hypertriglyceridaemia	2.0%
Hyperuricaemia	2.0%
Alcoholism	1.4%
Diabetes Mellitus Non-insulin-dependent	1.4%
Hiv Infection	1.4%
Hyperkalaemia	1.4%
Insomnia	1.4%
Product Used For Unknown Indication	1.4%
Arrhythmia Supraventricular	0.7%
Breast Cancer	0.7%
Cardiac Failure	0.7%

Haemolytic Anaemia	18.5%
Epistaxis	7.4%
Hypoglycaemia	7.4%
Renal Failure Acute	7.4%
Acute Pulmonary Oedema	3.7%
Bilirubin Conjugated Increased	3.7%
Bladder Cancer Stage Ii	3.7%
Bladder Transitional Cell Carcinoma Stage Ii	3.7%
Blood Triglycerides Increased	3.7%
Cardiomyopathy	3.7%
Condition Aggravated	3.7%
Fall	3.7%
Haemoptysis	3.7%
Hepatitis Fulminant	3.7%
Hyponatraemia	3.7%
Intra-uterine Death	3.7%
Myocardial Infarction	3.7%
Pancreatitis Acute	3.7%
Pemphigoid	3.7%
Performance Status Decreased	3.7%

Concomitant

Type 2 Diabetes Mellitus	19.0%
Colorectal Cancer Metastatic	14.4%
Non-small Cell Lung Cancer	9.8%
Diabetes Mellitus	7.8%
Diabetes Mellitus Non-insulin-dependent	7.8%
Product Used For Unknown Indication	7.8%
Hypertension	7.2%
Bladder Cancer	3.9%
Hepatic Neoplasm Malignant	2.6%
Phlebitis	2.6%
Acute Lymphocytic Leukaemia	2.0%
Angiogram	2.0%
Drug Use For Unknown Indication	2.0%
Metastatic Renal Cell Carcinoma	2.0%
Multiple Myeloma	2.0%
Neoplasm Malignant	2.0%
Acute Myeloid Leukaemia	1.3%
Arthralgia	1.3%
Atrial Fibrillation	1.3%
Bronchitis	1.3%

Weight Decreased	10.3%
Bladder Cancer	8.8%
Weight Increased	8.8%
Pulmonary Tuberculosis	7.4%
Troponin I Increased	7.4%
Somnolence	5.9%
Acute Pulmonary Oedema	4.4%
Bladder Transitional Cell Carcinoma	4.4%
Pyrexia	4.4%
Rash	4.4%
Skin Exfoliation	4.4%
Sudden Death	4.4%
Vomiting	4.4%
Drug Ineffective	2.9%
Hyperkalaemia	2.9%
Hypertension	2.9%
Hypoglycaemia	2.9%
Hypotension	2.9%
Knee Operation	2.9%
Melaena	2.9%